Ark Genomic Revolution Etf Probability of Future Etf Price Finishing Over 23.67

ARKG Etf  USD 25.56  0.57  2.18%   
ARK Genomic's future price is the expected price of ARK Genomic instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ARK Genomic Revolution performance during a given time horizon utilizing its historical volatility. Check out ARK Genomic Backtesting, Portfolio Optimization, ARK Genomic Correlation, ARK Genomic Hype Analysis, ARK Genomic Volatility, ARK Genomic History as well as ARK Genomic Performance.
  
Please specify ARK Genomic's target price for which you would like ARK Genomic odds to be computed.

ARK Genomic Target Price Odds to finish over 23.67

The tendency of ARK Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above $ 23.67  in 90 days
 25.56 90 days 23.67 
about 88.42
Based on a normal probability distribution, the odds of ARK Genomic to stay above $ 23.67  in 90 days from now is about 88.42 (This ARK Genomic Revolution probability density function shows the probability of ARK Etf to fall within a particular range of prices over 90 days) . Probability of ARK Genomic Revolution price to stay between $ 23.67  and its current price of $25.56 at the end of the 90-day period is about 59.98 .
Given the investment horizon of 90 days the etf has the beta coefficient of 1.82 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ARK Genomic will likely underperform. Additionally ARK Genomic Revolution has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   ARK Genomic Price Density   
       Price  

Predictive Modules for ARK Genomic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ARK Genomic Revolution. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
23.0925.5628.03
Details
Intrinsic
Valuation
LowRealHigh
22.9225.3927.86
Details
Naive
Forecast
LowNextHigh
24.1526.6329.10
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
22.4224.7727.13
Details

ARK Genomic Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ARK Genomic is not an exception. The market had few large corrections towards the ARK Genomic's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ARK Genomic Revolution, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ARK Genomic within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.11
β
Beta against Dow Jones1.82
σ
Overall volatility
1.07
Ir
Information ratio -0.0088

ARK Genomic Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ARK Genomic for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ARK Genomic Revolution can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ARK Genomic generated a negative expected return over the last 90 days
Latest headline from news.google.com: Cathie Woods ARK buys ABSI stock, sells BFLY and SNTI - Investing.com
ARK Genomic Revolution created five year return of -4.0%
This fund holds 99.63% of its assets under management (AUM) in equities

ARK Genomic Technical Analysis

ARK Genomic's future price can be derived by breaking down and analyzing its technical indicators over time. ARK Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ARK Genomic Revolution. In general, you should focus on analyzing ARK Etf price patterns and their correlations with different microeconomic environments and drivers.

ARK Genomic Predictive Forecast Models

ARK Genomic's time-series forecasting models is one of many ARK Genomic's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ARK Genomic's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.

Things to note about ARK Genomic Revolution

Checking the ongoing alerts about ARK Genomic for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ARK Genomic Revolution help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ARK Genomic generated a negative expected return over the last 90 days
Latest headline from news.google.com: Cathie Woods ARK buys ABSI stock, sells BFLY and SNTI - Investing.com
ARK Genomic Revolution created five year return of -4.0%
This fund holds 99.63% of its assets under management (AUM) in equities
When determining whether ARK Genomic Revolution is a strong investment it is important to analyze ARK Genomic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ARK Genomic's future performance. For an informed investment choice regarding ARK Etf, refer to the following important reports:
Check out ARK Genomic Backtesting, Portfolio Optimization, ARK Genomic Correlation, ARK Genomic Hype Analysis, ARK Genomic Volatility, ARK Genomic History as well as ARK Genomic Performance.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.